These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3855847)

  • 21. The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules.
    Crepaldi T; Richiardi P; Malavasi F; Carbonara AO; Igarashi M; Ferrone S
    Tissue Antigens; 1985 Jul; 26(1):25-34. PubMed ID: 2412306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line.
    DeMars R; Chang CC; Rudersdorf RA
    Hum Immunol; 1983 Oct; 8(2):123-39. PubMed ID: 6417067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-idiotypic antibodies to HLA-DR4 and DR2.
    Reed E; Bonagura V; Kung P; King DW; Suciu-Foca N
    J Immunol; 1983 Dec; 131(6):2890-4. PubMed ID: 6417234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A monoclonal antibody recognizing HLA-DR2 on malignant and activated cells.
    Fuggle SV; Kirkley J; Ting A; Morris PJ
    Immunogenetics; 1983; 18(4):415-28. PubMed ID: 6195109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-DS molecules and their relation to supertypic specificities.
    Goyert SM; Moriuchi J; Winchester R; Silver J
    Hum Immunol; 1983 Sep; 8(1):53-63. PubMed ID: 6195135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophoretic analysis of HLA-DR2 molecules isolated from HLA-Dw2 and HLA-Dw12 cell lines.
    Takenouchi T; Kasahara M; Ogasawara K; Ikeda H; Ishikawa N; Hawkin S; Wakisaka A; Aizawa M
    J Immunogenet; 1985 Feb; 12(1):65-9. PubMed ID: 3876392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A murine anti-I-Ak monoclonal antibody recognizes human DR (I-E-like) antigens.
    Hurley CK; Pierres M; Capra JD
    Hum Immunol; 1983 Apr; 6(4):199-205. PubMed ID: 6404862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A human helper-dependent influenza virus-specific cytotoxic T lymphocyte clone restricted by HLA-DR2.
    Fleischer B
    Tissue Antigens; 1985 Oct; 26(4):248-53. PubMed ID: 2933850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of normal and transformed lymphocyte subsets of nonhuman primates with monoclonal antibodies to human lymphocytes.
    Neubauer RH; Briggs CJ; Noer KB; Rabin H
    J Immunol; 1983 Mar; 130(3):1323-9. PubMed ID: 6296233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical dissection of DRw6 related epitopes using monoclonal antibodies.
    Johnson JP; Wank R
    Hum Immunol; 1986 May; 16(1):69-80. PubMed ID: 2423487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A monoclonal antibody with specificity to the HLA-DR1 and -DR51 antigens.
    Loh MT; Chan SH; Ren EC
    Tissue Antigens; 1993 Aug; 42(2):100-4. PubMed ID: 8266318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.
    Aparicio P; Jaraquemada D; López de Castro JA
    J Exp Med; 1987 Feb; 165(2):428-43. PubMed ID: 3102669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). I. Blocking of bulk non-DR and non-DQ-directed cytotoxic T cells by MoAb against DR, DQ, and DP.
    Strassmann G; Ress S; Anichini A; Bach FH
    Hum Immunol; 1985 Jun; 13(2):125-37. PubMed ID: 3874193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative expression of epitopes defined by murine monoclonal antibodies on DR molecules from different HLA haplotypes.
    Letarte M; Addis J; Iturbe S; Petsche D
    Biosci Rep; 1985; 5(10-11):923-31. PubMed ID: 2420387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell mediated PPD specific cytotoxicity against human monocyte targets: III. Cellular typing with CTLs restricted by class II HLA antigens.
    Hansen PW; Kristensen T
    Tissue Antigens; 1986 Apr; 27(4):227-38. PubMed ID: 2425454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sharing of Ia antigens between species. IV. Interspecies cross-reactivity of monoclonal antibodies directed against polymorphic mouse Ia determinants.
    Lunney JK; Osborne BA; Sharrow SO; Devaux C; Pierres M; Sachs DH
    J Immunol; 1983 Jun; 130(6):2786-93. PubMed ID: 6406596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity.
    Giles RC; Nunez G; Hurley CK; Nunez-Roldan A; Winchester R; Stastny P; Capra JD
    J Exp Med; 1983 May; 157(5):1461-70. PubMed ID: 6189938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.